Stay updated on Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial

Sign up to get notified when there's something new on the Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.
    Difference
    0.1%
    Check dated 2025-09-14T09:56:01.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.1%
    Check dated 2025-09-07T07:55:14.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of new facility names and locations across various countries, as well as updates to drug-related topics and terms. Notably, the content related to Trastuzumab Emtansine and Atezolizumab has been revised.
    Difference
    5%
    Check dated 2025-08-31T01:08:11.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page has updated its version from v2.16.11 to v2.16.12, indicating a revision in the content. Additionally, the previous estimated timestamps for 'Results First Posted' and 'Last Update Posted' have been removed.
    Difference
    0.1%
    Check dated 2025-08-16T20:20:41.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The study has expanded to include 51 locations and the results have been posted as of August 8, 2025. However, several key outcome measures related to the study have been removed due to the sponsor's decision to prematurely terminate the study.
    Difference
    80%
    Check dated 2025-08-09T15:40:42.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.10, and the previous service alert regarding planned maintenance has been removed.
    Difference
    0.9%
    Check dated 2025-08-02T14:23:26.000Z thumbnail image

Stay in the know with updates to Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial page.